BR
Brazzell Romulus K
Directeur Médical
OtherM
€140,622
▼ Sales (10 ops.)
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Brazzell Romulus K, Directeur Médical. Officer active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €141k. Activity tracked since 28 June 2021. The latest transaction was filed on 22 October 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Brazzell Romulus K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
46,748 shares@ US$0.8333.6% of flowCommon StockSEC:0001298079-25-000003:0
5,251 shares@ US$4.0127.5% of flowCommon StockSEC:0001415889-25-018318:0
3,687 shares@ US$3.7425.4% of flowCommon StockSEC:0001415889-25-015678:0
10,100 shares0Common StockSEC:0001415889-25-001061:0
5,489 shares@ US$4.7568.5% of flowCommon StockSEC:0001415889-24-018373:0
2,002 shares@ US$6.0931.5% of flowCommon StockSEC:0001415889-24-015223:0
6,500 shares0Common StockSEC:0001415889-24-000770:0
49,356 shares0Common StockSEC:0001415889-23-010284:0
17,916 sharesCommon StockSEC:0001415889-23-009135:0
12,800 shares0Common StockSEC:0001415889-23-000638:0
261 shares@ US$6.512.1% of flowCommon StockSEC:0001415889-22-010879:0
3,144 shares@ US$0.370.0071% mcap1.4% of flowCommon StockSEC:0001415889-22-007061:0
3,504 shares@ US$1.309.8% of flowCommon StockSEC:0001415889-22-000404:0
12,757 shares@ US$1.8048.0% of flowCommon StockSEC:0001415889-21-005010:0
3,034 shares@ US$5.7735.5% of flowCommon StockSEC:0001415889-21-003258:0
About Brazzell Romulus K
Brazzell Romulus K is Directeur Médical at Kala Pharmaceuticals, Inc. and KALA BIO, Inc. Across 15 filings in total, the 15 sampled filings run from 2021-06-29 to 2025-10-24 and show EUR 0 of buys and EUR 140622 of sells, with the transaction nature listed as Cession.